Review of ruxolitinib for systemic juvenile arthritis with macrophage activation syndrome
Two children with severe arthritis found relief using a new drug approach
This narrative review synthesizes a retrospective case series and literature search on ruxolitinib for systemic juvenile idiopathic arthriti…
Two children with severe arthritis complications found relief using a new drug approach, offering hope for those who struggle with standard …
Machine learning models predict macrophage activation syndrome risk in 737 patients with Still's disease
New Tool Predicts Dangerous Fever Flare
This multicenter, prospective observational study analyzed 737 patients with Still's disease to identify risk factors for macrophage activat…
A new tool predicts dangerous fever flares in Still's disease by spotting high-risk signs like age, ferritin levels, and inflammation marker…